Guidelines Developed for Peri-Op, Post-Op Rhinoplasty Care

Share this content:
Guidelines Developed for Peri-Op, Post-Op Rhinoplasty Care
Guidelines Developed for Peri-Op, Post-Op Rhinoplasty Care

THURSDAY, Feb. 2, 2017 (HealthDay News) -- A new clinical practice guideline, published in the February issue of Otolaryngology-Head and Neck Surgery, offers recommendations for clinicians who perform rhinoplasty and those who are involved in care for rhinoplasty candidates.

Lisa E. Ishii, M.D., from Johns Hopkins University in Baltimore, and colleagues used current evidence-based medicine practices and data to provide recommendations for perioperative and postoperative rhinoplasty care.

The researchers note that all patients seeking rhinoplasty should be asked about their motivations for surgery and expectations for outcomes; this discussion should be documented in the medical record. Rhinoplasty candidates should be assessed for comorbid conditions that could impact surgery. During the preoperative assessment, rhinoplasty candidates should be evaluated for nasal airway obstruction. Candidates for surgery with obstructive sleep apnea should be educated regarding expectations after surgery and perioperative management. Patients should be educated about strategies to manage discomfort after surgery. Patient satisfaction with their nasal appearance and function should be documented at least 12 months after rhinoplasty. Antibiotics administered perioperatively should not be routinely prescribed for a duration >24 hours after surgery; packing should not be routinely placed in the nasal cavity of rhinoplasty patients at the end of surgery.

"The impetus for this guideline is to utilize current evidence-based medicine practices and data to build unanimity regarding the peri- and postoperative strategies to maximize patient safety and to optimize surgical results for patients," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »